Burning mouth syndrome: Current concepts

Cibele Nasri-Heir, Julyana Gomes Zagury, Davis Thomas, Sowmya Ananthan

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Burning mouth syndrome (BMS) is a chronic pain condition. It has been described by the International Headache Society as “an intra-oral burning or dysesthetic sensation, recurring daily for more than 2 h/day for more than 3 months, without clinically evident causative lesions.” BMS is frequently seen in women in the peri-menopausal and menopausal age group in an average female/male ratio of 7:1. The site most commonly affected is the anterior two-thirds of the tongue. The patient may also report taste alterations and oral dryness along with the burning. The etiopathogenesis is complex and is not well-comprehended. The more accepted theories point toward a neuropathic etiology, but the gustatory system has also been implicated in this condition. BMS is frequently mismanaged, partly because it is not well-known among healthcare providers. Diagnosis of BMS is made after other local and systemic causes of burning have been ruled out as then; the oral burning is the disease itself. The management of BMS still remains a challenge. Benzodiazepines have been used in clinical practice as the first-line medication in the pharmacological management of BMS. Nonpharmacological management includes cognitive behavioral therapy and complementary and alternative medicine (CAM). The aim of this review is to familiarize healthcare providers with the diagnosis, pathogenesis, and general characteristics of primary BMS while updating them with the current treatment options to better manage this group of patients.

Original languageEnglish (US)
Pages (from-to)300-307
Number of pages8
JournalJournal of Indian Prosthodontist Society
Volume15
Issue number4
DOIs
StatePublished - Jan 1 2015

Fingerprint

Burning Mouth Syndrome
Complementary Therapies
Health Personnel
Xerostomia
Cognitive Therapy
Benzodiazepines
Tongue
Chronic Pain
Headache
Age Groups
Pharmacology

All Science Journal Classification (ASJC) codes

  • Oral Surgery
  • Dentistry(all)

Keywords

  • Burning mouth syndrome
  • Neuropathic pain
  • Orofacial pain

Cite this

Nasri-Heir, Cibele ; Zagury, Julyana Gomes ; Thomas, Davis ; Ananthan, Sowmya. / Burning mouth syndrome : Current concepts. In: Journal of Indian Prosthodontist Society. 2015 ; Vol. 15, No. 4. pp. 300-307.
@article{eb0c8821dfcf42288389513a5c61abdc,
title = "Burning mouth syndrome: Current concepts",
abstract = "Burning mouth syndrome (BMS) is a chronic pain condition. It has been described by the International Headache Society as “an intra-oral burning or dysesthetic sensation, recurring daily for more than 2 h/day for more than 3 months, without clinically evident causative lesions.” BMS is frequently seen in women in the peri-menopausal and menopausal age group in an average female/male ratio of 7:1. The site most commonly affected is the anterior two-thirds of the tongue. The patient may also report taste alterations and oral dryness along with the burning. The etiopathogenesis is complex and is not well-comprehended. The more accepted theories point toward a neuropathic etiology, but the gustatory system has also been implicated in this condition. BMS is frequently mismanaged, partly because it is not well-known among healthcare providers. Diagnosis of BMS is made after other local and systemic causes of burning have been ruled out as then; the oral burning is the disease itself. The management of BMS still remains a challenge. Benzodiazepines have been used in clinical practice as the first-line medication in the pharmacological management of BMS. Nonpharmacological management includes cognitive behavioral therapy and complementary and alternative medicine (CAM). The aim of this review is to familiarize healthcare providers with the diagnosis, pathogenesis, and general characteristics of primary BMS while updating them with the current treatment options to better manage this group of patients.",
keywords = "Burning mouth syndrome, Neuropathic pain, Orofacial pain",
author = "Cibele Nasri-Heir and Zagury, {Julyana Gomes} and Davis Thomas and Sowmya Ananthan",
year = "2015",
month = "1",
day = "1",
doi = "10.4103/0972-4052.171823",
language = "English (US)",
volume = "15",
pages = "300--307",
journal = "The Journal of Indian Prosthodontic Society",
issn = "0972-4052",
publisher = "Springer India",
number = "4",

}

Burning mouth syndrome : Current concepts. / Nasri-Heir, Cibele; Zagury, Julyana Gomes; Thomas, Davis; Ananthan, Sowmya.

In: Journal of Indian Prosthodontist Society, Vol. 15, No. 4, 01.01.2015, p. 300-307.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Burning mouth syndrome

T2 - Current concepts

AU - Nasri-Heir, Cibele

AU - Zagury, Julyana Gomes

AU - Thomas, Davis

AU - Ananthan, Sowmya

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Burning mouth syndrome (BMS) is a chronic pain condition. It has been described by the International Headache Society as “an intra-oral burning or dysesthetic sensation, recurring daily for more than 2 h/day for more than 3 months, without clinically evident causative lesions.” BMS is frequently seen in women in the peri-menopausal and menopausal age group in an average female/male ratio of 7:1. The site most commonly affected is the anterior two-thirds of the tongue. The patient may also report taste alterations and oral dryness along with the burning. The etiopathogenesis is complex and is not well-comprehended. The more accepted theories point toward a neuropathic etiology, but the gustatory system has also been implicated in this condition. BMS is frequently mismanaged, partly because it is not well-known among healthcare providers. Diagnosis of BMS is made after other local and systemic causes of burning have been ruled out as then; the oral burning is the disease itself. The management of BMS still remains a challenge. Benzodiazepines have been used in clinical practice as the first-line medication in the pharmacological management of BMS. Nonpharmacological management includes cognitive behavioral therapy and complementary and alternative medicine (CAM). The aim of this review is to familiarize healthcare providers with the diagnosis, pathogenesis, and general characteristics of primary BMS while updating them with the current treatment options to better manage this group of patients.

AB - Burning mouth syndrome (BMS) is a chronic pain condition. It has been described by the International Headache Society as “an intra-oral burning or dysesthetic sensation, recurring daily for more than 2 h/day for more than 3 months, without clinically evident causative lesions.” BMS is frequently seen in women in the peri-menopausal and menopausal age group in an average female/male ratio of 7:1. The site most commonly affected is the anterior two-thirds of the tongue. The patient may also report taste alterations and oral dryness along with the burning. The etiopathogenesis is complex and is not well-comprehended. The more accepted theories point toward a neuropathic etiology, but the gustatory system has also been implicated in this condition. BMS is frequently mismanaged, partly because it is not well-known among healthcare providers. Diagnosis of BMS is made after other local and systemic causes of burning have been ruled out as then; the oral burning is the disease itself. The management of BMS still remains a challenge. Benzodiazepines have been used in clinical practice as the first-line medication in the pharmacological management of BMS. Nonpharmacological management includes cognitive behavioral therapy and complementary and alternative medicine (CAM). The aim of this review is to familiarize healthcare providers with the diagnosis, pathogenesis, and general characteristics of primary BMS while updating them with the current treatment options to better manage this group of patients.

KW - Burning mouth syndrome

KW - Neuropathic pain

KW - Orofacial pain

UR - http://www.scopus.com/inward/record.url?scp=84952766593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952766593&partnerID=8YFLogxK

U2 - 10.4103/0972-4052.171823

DO - 10.4103/0972-4052.171823

M3 - Review article

AN - SCOPUS:84952766593

VL - 15

SP - 300

EP - 307

JO - The Journal of Indian Prosthodontic Society

JF - The Journal of Indian Prosthodontic Society

SN - 0972-4052

IS - 4

ER -